Cardiogenic shock

Common Name(s)

Cardiogenic shock

Cardiogenic shock occurs when the heart has been damaged to the point where it cannot pump enough blood to the rest of the body. This condition is usually due to serious heart complications. These complications may occur during or after a severe heart attack and include damage to the heart muscle (stopping the heart from pumping), dangerous heart rhythms, pressure on the heart caused by fluid buildup, problems with the heart’s electrical system, a very slow heart rhythm, or damage to the heart valves (control flow of blood) or septums (walls which separate the four heart chambers).

Symptoms include rapid breathing and heartbeat (tachycardia), shortness of breath, and a loss of consciousness. Other symptoms include a weak pulse, sweating, pale skin, cold hands or feet, or urinating less than normal. About 7% of those who have a heart attack also develop cardiogenic shock.

Cardiogenic shock can also be caused by infections of the heart or a drug overdose. Other risk factors include diabetes, high blood pressure, coronary artery disease, smoking, lack of exercise, or a history of heart failure or heart attacks. Age and certain genetic and congenital (present at birth) conditions may also increase your risk.

Cardiogenic shock is a medical emergency. Tests to look for the cause may include a blood pressure test, EKG, echocardiogram, cardiac enzyme and other blood tests, chest X-ray, coronary angiograph, and cardiac catheterization. Increasing blood flow and oxygen to body’s organ is the most immediate focus. Further treatment will depend on the underlying cause but may include medication, insertion of a medical device (e.g. pacemakers) and surgery. Research is ongoing, so talk to your cardiologist about current treatment options if a family member has been diagnosed with cardiogenic shock. Support groups are a good source of information and support.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Cardiogenic shock" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Cardiogenic shock" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Cardiogenic shock" returned 432 free, full-text research articles on human participants. First 3 results:

Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis.
 

Author(s): Qing Rui, Yufeng Jiang, Min Chen, Nannan Zhang, Huajia Yang, Yafeng Zhou

Journal: Medicine (Baltimore). 2017 Oct;96(43):e8402.

 

Guidelines recommend that norepinephrine (NA) should be used to reach the target mean arterial pressure (MAP) during cardiogenic shock (CS), rather than epinephrine and dopamine (DA). However, there has actually been few studies on comparing norepinephrine with dopamine and their ...

Last Updated: 25 Oct 2017

Go To URL
Acquired von Willebrand syndrome in cardiogenic shock patients on mechanical circulatory microaxial pump support.
 

Author(s): Ulrike Flierl, Jörn Tongers, Dominik Berliner, Jan-Thorben Sieweke, Florian Zauner, Christoph Wingert, Christian Riehle, Johann Bauersachs, Andreas Schäfer

Journal:

 

Early use of mechanical circulatory support, e.g. veno-arterial extracorporeal membrane oxygenation (ECMO) or left ventricular unloading by microaxial pump in refractory cardiogenic shock is recommended in current guidelines. Development of acquired von Willebrand Syndrome (AVWS) ...

Last Updated: 14 Aug 2017

Go To URL
Impact of Intravenous P2Y12-Receptor Inhibition with Cangrelor in Patients Presenting with Acute Coronary Syndrome and Cardiogenic Shock - a Case Series.
 

Author(s): Michal Droppa, Oliver Borst, Dominik Rath, Karin Müller, Meinrad Gawaz, Deepak L Bhatt, Tobia Geisler

Journal: Cell. Physiol. Biochem.. 2017 ;42(4):1336-1341.

 

Patients with acute coronary syndromes (ACS) presenting with cardiogenic shock (CS) are at particular risk for death and adverse cardiac events. Impaired effects and absorption of oral P2Y12-receptor inhibitors due to decreased organ hypoperfusion or hypothermia and challenges regarding ...

Last Updated: 12 Jul 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Cardiogenic shock" returned 45 free, full-text review articles on human participants. First 3 results:

Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis.
 

Author(s): Maziar Khorsandi, Scott Dougherty, Omar Bouamra, Vasudev Pai, Philip Curry, Steven Tsui, Stephen Clark, Stephen Westaby, Nawwar Al-Attar, Vipin Zamvar

Journal:

 

Postcardiotomy cardiogenic shock (PCCS) refractory to inotropic support and intra-aortic balloon pump (IABP) occurs rarely but is almost universally fatal without mechanical circulatory support. In this systematic review and meta-analysis we looked at the evidence behind the use of ...

Last Updated: 18 Jul 2017

Go To URL
ECMO in cardiac arrest and cardiogenic shock.
 

Author(s): L C Napp, C Kühn, J Bauersachs

Journal: Herz. 2017 Feb;42(1):27-44.

 

Cardiogenic shock is an acute emergency, which is classically managed by medical support with inotropes or vasopressors and frequently requires invasive ventilation. However, both catecholamines and ventilation are associated with a worse prognosis, and many patients deteriorate despite ...

Last Updated: 27 Jan 2017

Go To URL
Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis.
 

Author(s): Dagmar M Ouweneel, Jasper V Schotborgh, Jacqueline Limpens, Krischan D Sjauw, A E Engström, Wim K Lagrand, Thomas G V Cherpanath, Antoine H G Driessen, Bas A J M de Mol, José P S Henriques

Journal: Intensive Care Med. 2016 Dec;42(12):1922-1934.

 

Veno-arterial extracorporeal life support (ECLS) is increasingly used in patients during cardiac arrest and cardiogenic shock, to support both cardiac and pulmonary function. We performed a systematic review and meta-analysis of cohort studies comparing mortality in patients treated ...

Last Updated: 20 Sep 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Cardiogenic Shock Intravascular Cooling Trial
 

Status: Recruiting

Condition Summary: Cardiogenic Shock

 

Last Updated: 8 Nov 2017

Go to URL
Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic Shock
 

Status: Not yet recruiting

Condition Summary: Cardiogenic Shock

 

Last Updated: 8 Nov 2017

Go to URL
Hemodynamic Assessment in Cardiogenic Shock Regarding the Etiology
 

Status: Not yet recruiting

Condition Summary: Cardiogenic Shock

 

Last Updated: 21 Sep 2017

Go to URL